 |
|
|
| |
Patterns of Antiretroviral Use and Immunologic Correlates at Study Entry in the REPRIEVE Trial
|
| |
| |
IAC 2020
Reported by Jules Levin July 6-10 virtual
Carl J. Fichtenbaum,1 Heather J. Ribaudo, PhD2, Jorge Leon-Cruz, MS2, Edgar T. Overton, MD3,
Markella V. Zanni, MD4, Carlos D. Malvestutto, MD, MPH5, Judith A. Aberg, MD6, Emma M. Kileel,
MPH4, Kathleen V. Fitch, MSN4, Marije Van Schalkwyk, MD7, Nagalingeswaran Kumarasamy, MD8,
Esteban Martinez, MD9, Breno Riegel Santos, MD10, Yvetot Joseph, MD11, Janet Lo, MD4,
Sue Siminski, MS, MBA12, Kathleen Melbourne, PharmD13, Craig A. Sponseller, MD14,
Patrice Desvigne-Nickens, MD15, Gerald S. Bloomfield, MD, MPH16, Judith S. Currier, MD, MSc17,
Udo Hoffmann, MD, MPH18, Pamela S. Douglas, MD19, Steven K. Grinspoon, MD4
on behalf of the REPRIEVE Investigators.
|
| |
|
|
|
|
|
